I see it as the FDA still refuses to give Leronlimab a chance. It is a way to control the efficacy numbers for the total trial. It is an open study of a treatment that has been shown to have its best efficacy at 700mg, with no serious adverse events. Yet, the FDA makes us do half of the trial at half of the dose. It is not fair to us! It is not fair to the person dying from Colorectal Cancer! It is just meddling, muddying up the possible great results, and cutting the strength of the trial in half. If we show a great response, at a proper dose, they will say we are cherry picking our results. It just feels like Deja Vu to me.